Task: Answer the multiple-choice question.
Query: Which drug has a 2.196\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cn1c(NC(=O)C[n+]2cc(-c3ccc(Cl)cc3)n3c2CCC3)cc(=O)n(C)c1=O.[Cl-]
b Cn1ccnc1SCC(=O)Nc1ccc(Cl)cn1
c COc1ccc(C(=O)Nc2ccc(NC(=O)C3CC3)nc2)cc1
d O=C(Nc1c(F)cccc1F)c1ccc2c(c1)CCN2S(=O)(=O)c1ccccc1
Answer: b. Cn1ccnc1SCC(=O)Nc1ccc(Cl)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ccnc1SCC(=O)Nc1ccc(Cl)cn1
Cn1ccnc1SCC(=O)Nc1ccc(Cl)cn1
N-(5-chloropyridin-2-yl)-2-(1-methylimidazol-2-yl)sulfanylacetamide